1,212
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality

ORCID Icon, , , &
Pages 220-228 | Received 20 Feb 2020, Accepted 12 Sep 2020, Published online: 15 Oct 2020
 

ABSTRACT

Background: A cascade of care (CoC) model may improve understanding of gaps in addiction treatment availability and quality over current single measure methods. Despite increased funding, opioid overdose rates remain high. Therefore, it is critical to understand where the health-care system is failing to provide appropriate care for people with opioid use disorder (OUD) diagnoses, and to assess disparities in receipt of medication for OUD (MOUD).

Objective: Using a CoC framework, assess treatment quality and outcomes for OUD in the Florida Medicaid population in 2017/2018 by demographics and primary vs. secondary diagnosis.

Methods: Data from Florida Medicaid claims for 2017 and 2018 were used to calculate the number of enrollees who were diagnosed, began MOUD, were retained on medication for a minimum of 180 days, and who died.

Results: Only 28% of those diagnosed with OUD began treatment with an FDA approved MOUD (buprenorphine, methadone, or injectable naltrexone). Once on medication, 38% of newly diagnosed enrollees were retained in treatment for180 days. Those who remained on MOUD for 180 days had a hazard ratio of death of 0.226 (95% CI = 0.174 to 0.294) compared to those that did not initiate MOUD, a reduction in mortality from 10% without MOUD to 2% with MOUD.

Conclusions: Initiating medication after OUD diagnosis offers the greatest opportunity for intervention to reduce overdose deaths, though efforts to increase retention are also warranted. Analyzing claims data with CoC identifies system functioning for specific populations, and suggests policies and clinical pathways to target for improvement.

Additional information

Funding

We thank the National Institute on Drug Abuse (NIDA) for support for this paper through grants [R01DA037222-05S1] (McGovern PI; McGovern and Brown, effort), [P30 DA027828] (Brown PI; Brown effort), and the National Center for Advancing Translational Sciences, (NCATS) grant [UL1TR001422] (Lloyd-Jones PI, Brown effort), and the Florida Agency for Health Care Administration contract (Florida Medicaid Drug Therapy Management Program For Behavioral Health, data for analysis). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 987.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.